1 / 14

Manish Khullar Richard Slavik Sean Gorman Nicole Bruchet Sarah Murray Brett Hamilton Dawn Dalen

Contribution of Hospital Pharmacy Residents to Resolution of Drug Therapy Problems for Patients: RES-DTP Study. Manish Khullar Richard Slavik Sean Gorman Nicole Bruchet Sarah Murray Brett Hamilton Dawn Dalen Victoria Slavik. Background.

kirk-may
Download Presentation

Manish Khullar Richard Slavik Sean Gorman Nicole Bruchet Sarah Murray Brett Hamilton Dawn Dalen

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Contribution of Hospital Pharmacy Residents to Resolution of Drug Therapy Problems for Patients: RES-DTP Study Manish Khullar Richard Slavik Sean Gorman Nicole Bruchet Sarah Murray Brett Hamilton Dawn Dalen Victoria Slavik

  2. Background • Priority disease states account for a significant number of ED visits, hospital admissions, prolonged lengths of stay and increased costs • RCTs have shown that pharmacists providing proactive, evidence-based activities to resolve DTPs for patients with priority disease states can improve the overall quality of drug therapy, and reduce ED visits, readmissions, costs

  3. Background • To promote clinical pharmacist continuous professional development (CPD), disease state education modules (DSEMs) for priority disease states were implemented at IH in 2009 • DSEMs improve the knowledge, skills, abilities, competence, and confidence of pharmacists and improve accepted process of care measures (DTPs, DSEM DTPs and DSEM KPIs)

  4. Background • Pharmacist-resolved DTPs is the primary clinical performance indicator at IH and part of the recommended bundle of Canadian clinical pharmacy key performance indicators (cpKPIs) • From Aug 1/2012 to July 31/2013, IH pharmacists resolved 27, 564 DTPs, of which 10, 911 (40%) were DSEM DTPs, and 7834 (28%) DSEM KPIs

  5. Rationale • Providing evidence-based clinical activities and resolving DTPs is a major goal for professional development during the IH Pharmacy Practice Residency Program • Limited observational data and a systematic review suggest that U.S. entry to practice PharmD students and residents may contribute to “clinical activities” or “clinical interventions” during experiential rotations • There are no data on the contribution of Canadian pharmacy practice residents to clinical activities or resolved DTPs during their experiential rotations

  6. Rationale • At IH, a recently completed study on perceived benefits and barriers to residency precepting identified discordance in the perception of resident contributions to DTP resolution • Current preceptors vs non-preceptors, and staff pharmacists vs managers were more likely to state that pharmacy residents contribute to DTP resolution for patients • There are currently no data on resolution of DTPs by IH pharmacy residents

  7. Purpose and Objectives • Purpose: • To describe the contribution of hospital pharmacy residents to clinical pharmacy care using accepted process of care measures, and capture resident perceptions of DTP tracking • Primary Objective: • To determine the number of DTPs resolved by IH pharmacy residents

  8. Secondary Objectives • To determine the number of DSEM DTPs resolved by IH pharmacy residents • To determine the number of KPIs resolved by IH pharmacy residents • To determine the number of DTPs, DSEM DTPs, and DSEM KPIs resolved by IH pharmacy residents over time • To collect focus group feedback on perceptions of DTP tracking from IH pharmacy residents

  9. Significance • Will help quantify contribution of IH pharmacy residents to evidence-based clinical activities and resolved DTPs, and identify if training procedures need to be modified to promote real world contribution of IH pharmacy residents • Relevance to Canadian hospital pharmacy residency programs

  10. Methods • Design • Prospective, observational, one group study to determine the contribution of hospital pharmacy residents to clinical process of care measures • Setting • Kelowna General Hospital (KGH), Royal Inland Hospital (RIH), Penticton Regional Hospital (PRH), East Kootenay Regional Hospital (EKH) and Kootenay Lake Hospital from July 29, 2013 to June 13, 2014

  11. Methods • Inclusion Criteria • DTP Tracker data collated from all IH hospital pharmacy residents after the completion of the first 4 week patient care rotation (ie. Internal Medicine rotation) will be included • Exclusion Criteria • DTP Tracker data that is un-interpretable due to manipulation of standard pull-down field options, free text options, or incomplete entry of resolved DTPs will be excluded

  12. Methods • Primary Outcomes: • Number of DTPs resolved by IH pharmacy residents • Secondary Outcomes: • Number of DSEM DTPs resolved by IH pharmacy residents • Number of DSEM DTPs and DSEM KPIs resolved by IH pharmacy residents • Number of DTPs, DSEM DTPs, and DSEM KPIs resolved by IH pharmacy residents over time • Focus group feedback on perceptions of DTP tracking from IH pharmacy residents

  13. QUESTIONS?

More Related